导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.30% | 2620/4982 |
| 近一周 | -4.72% | 5145/5419 |
| 近一月 | 1.63% | 360/5423 |
| 近一季 | 3.34% | 557/5376 |
| 近半年 | -10.30% | 3799/5131 |
| 近一年 | 5.21% | 2187/4741 |
| 近两年 | 137.96% | 532/4208 |
| 近三年 | 104.83% | 392/3661 |
| 成立以来 | 268.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.55% 633/5130 |
-15.45% 4903/5464 |
- - |
- - |
| 2025 | 70.98% 296/5130 |
13.42% 345/4624 |
23.98% 38/4802 |
14.04% 3637/4970 |
6.62% 420/5130 |
| 2024 | 7.46% 1375/4618 |
-18.10% 4149/4340 |
-7.95% 3718/4442 |
26.44% 44/4550 |
12.73% 187/4618 |
| 2023 | 5.52% 121/4216 |
-2.88% 2975/3759 |
-9.13% 3180/3909 |
10.65% 3/4055 |
8.06% 48/4209 |
| 2022 | -24.36% 1726/3578 |
-12.09% 497/2804 |
5.41% 1927/3205 |
-14.92% 2360/3430 |
-4.06% 2403/3570 |
| 2021 | 2.13% 898/2717 |
-1.13% 521/1745 |
3.76% 1483/2232 |
-0.31% 697/2560 |
-0.13% 1571/2708 |
| 2020 | 29.59% 827/1596 |
-7.82% 880/1036 |
9.57% 977/1256 |
15.73% 291/1472 |
10.87% 1005/1690 |
| 2019 | 31.27% 541/926 |
27.03% 709/3054 |
-3.59% 2300/3201 |
-2.33% 864/939 |
9.75% 382/1014 |
| 2018 | -17.67% 101/668 |
- - |
- - |
- - |
-9.19% 1796/2977 |
| 2017 | -5.47% 421/531 |
- - |
- - |
- - |
- - |
| 2016 | -9.96% 157/455 |
- - |
- - |
- - |
- - |
| 2015 | 45.28% 211/433 |
- - |
- - |
- - |
- - |
| 2014 | 33.75% 109/432 |
- - |
- - |
- - |
- - |
| 2013 | 24.97% 93/398 |
- - |
- - |
- - |
- - |
| 2012 | -4.99% 438/459 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 诺安多策略混合 VS. 长安宏观策略混合A(740001) |